Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-035254
Filing Date
2021-09-07
Accepted
2021-09-07 17:04:47
Documents
1
Period of Report
2021-08-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7435
  Complete submission text file 0000899243-21-035254.txt   10368
Mailing Address C/O COLUMN GROUP LP 1700 OWENS STREET, SUITE 500 SAN FRANCISCO CA 94158
Business Address
GOEDDEL DAVID V (Reporting) CIK: 0001182464 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39866 | Film No.: 211239937

Mailing Address 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158 4158652050
COLUMN GROUP II, LP (Reporting) CIK: 0001600420 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39866 | Film No.: 211239938

Mailing Address 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address
Svennilson Peter (Reporting) CIK: 0001606074 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39866 | Film No.: 211239939

Mailing Address 1700 OWENS STREET, SUITE 500 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET, SUITE 500 SAN FRANCISCO CA 94158 415-865-2050
Column Group II GP, LP (Reporting) CIK: 0001645333 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39866 | Film No.: 211239940

Mailing Address 200 CLARENDON STREET, 51ST FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET, 51ST FLOOR BOSTON MA 02116 2157319450
eFFECTOR Therapeutics, Inc. (Issuer) CIK: 0001828522 (see all company filings)

EIN.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations